The Challenge
FDA mandated the validation of reprocessing Instructions for Use (rIFU) of reusable endoscopes after increased incidents of post use related infections. The mandate included a 522 postmarket surveillance study to validate the reprocessing training and rIFU.
Due to the length and complexity of current training practices and rIFUs, end users often did not reference materials intended to aid in the reprocessing steps.
Unique challenges included: